Epstein–Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases
International Journal of Molecular Sciences · 26.07.2024 · 25 (15) · 8160
DOI: 10.3390/ijms25158160 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.07.2024. Verfasst von Yuehong Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Autoimmune Diseases, Epstein-Barr Virus Infections, Immune Evasion. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Fund of China, the University Developmental Fund, the Chinese University of Hong Kong, Shenzhen, China (C.L.), Shenzhen-Hong Kong Cooperation Zone for Technology and Innovation.
Abstract (Originalsprache)
Epstein–Barr virus (EBV), a member of the γ-herpesvirus family, is one of the most prevalent and persistent human viruses, infecting up to 90% of the adult population globally. EBV’s life cycle includes primary infection, latency, and lytic reactivation, with the virus primarily infecting B cells and epithelial cells. This virus has evolved sophisticated strategies to evade both innate and adaptive immune responses, thereby maintaining a lifelong presence within the host. This persistence is facilitated by the expression of latent genes such as EBV nuclear antigens (EBNAs) and latent membrane proteins (LMPs), which play crucial roles in viral latency and oncogenesis. In addition to their well-known roles in several types of cancer, including nasopharyngeal carcinoma and B-cell lymphomas, recent studies have identified the pathogenic roles of EBV in autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus. This review highlights the intricate interactions between EBV and the host immune system, underscoring the need for further research to develop effective therapeutic and preventive strategies against EBV-associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
- Ciechanover Institute of Precision and Regenerative Medicine, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
ORCID-Profile: Chenzhong Li
Förderung
- National Science Fund of China
- the University Developmental Fund, the Chinese University of Hong Kong, Shenzhen, China (C.L.)
- Shenzhen-Hong Kong Cooperation Zone for Technology and Innovation
- Shenzhen Science and Technology Program
- Guangdong Basic and Applied Basic Research Foundation
- University Developmental Fund, The Chinese University of Hong Kong
Zitieren
APA
Zhao, Y., Zhang, Q., Zhang, B., Dai, Y., Gao, Y., Li, C., Yu, Y., & Li, C. (2024). Epstein–Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases. International Journal of Molecular Sciences, 25(15), 8160. https://doi.org/10.3390/ijms25158160
Vancouver
Zhao Y, Zhang Q, Zhang B, Dai Y, Gao Y, Li C, et al. Epstein–Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases. International Journal of Molecular Sciences. 2024;25(15):8160. doi:10.3390/ijms25158160
BibTeX
@article{Zhao2024,
author = {Zhao, Yuehong and Zhang, Qi and Zhang, Botian and Dai, Yihao and Gao, Yifei and Li, Chenzhong and Yu, Yijing and Li, Conglei},
title = {Epstein–Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {15},
pages = {8160},
doi = {10.3390/ijms25158160}
}
EUVIMED